Evidence map›Paper›PMID 38522094›Full record

ArticleBlood advances2024

Machine learning to optimize automated RH genotyping using whole-exome sequencing data.

Ti-Cheng Chang, Jing Yu, Zhaoming Wang, Jane S Hankins, Mitchell J Weiss, Gang Wu, Connie M Westhoff, Stella T Chou, Yan Zheng

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00760656 recruitingnot on this map

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

TypeobservationalSponsorSt. Jude Children's Research HospitalRan2007 to 2035Enrolled10,000ConditionsCancer
NCT02098863 recruitingnot on this map

Sickle Cell Clinical Research and Intervention Program

Typeobservational_patient_registrySponsorSt. Jude Children's Research HospitalRan2014 to 2044Enrolled10,000ConditionsSickle Cell Disease
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ti-Cheng ChangCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Jing YuDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Zhaoming WangDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-7556-3869
Jane S HankinsDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-4439-7321
Mitchell J WeissDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Gang WuCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Connie M WesthoffLaboratory of Immunohematology and Genomics, New York Blood Center Enterprises, New York, NY.
Stella T ChouDepartment of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA.ORCID 0000-0003-4333-6965
Yan ZhengDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-7254-7564
St. Jude Children's Research Hospital · USChildren's Hospital of Philadelphia · USNew York Blood Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
RH genotype matched red cell transfusions for patients with sickle cell diseaseR01HL147879 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHOU, STELLA T · 2019 to 2022
$3.4M
NCI NIH HHS P30 CA021765NHLBI NIH HHS R01 HL147879
6 · The paper itself

Abstract

abstractRh phenotype matching reduces but does not eliminate alloimmunization in patients with sickle cell disease (SCD) due to RH genetic diversity that is not distinguishable by serological typing. RH genotype matching can potentially mitigate Rh alloimmunization but comprehensive and accessible genotyping methods are needed. We developed RHtyper as an automated algorithm to predict RH genotypes using whole-genome sequencing (WGS) data with high accuracy. Here, we adapted RHtyper for whole-exome sequencing (WES) data, which are more affordable but challenged by uneven sequencing coverage and exacerbated sequencing read misalignment, resulting in uncertain predictions for (1) RHD zygosity and hybrid alleles, (2) RHCE∗C vs. RHCE∗c alleles, (3) RHD c.1136C>T zygosity, and (4) RHCE c.48G>C zygosity. We optimized RHtyper to accurately predict RHD and RHCE genotypes using WES data by leveraging machine learning models and improved the concordance of WES with WGS predictions from 90.8% to 97.2% for RHD and 96.3% to 98.2% for RHCE among 396 patients in the Sickle Cell Clinical Research and Intervention Program. In a second validation cohort of 3030 cancer survivors (15.2% Black or African Americans) from the St. Jude Lifetime Cohort Study, the optimized RHtyper reached concordance rates between WES and WGS predications to 96.3% for RHD and 94.6% for RHCE. Machine learning improved the accuracy of RH predication using WES data. RHtyper has the potential, once implemented, to provide a precision medicine-based approach to facilitate RH genotype-matched transfusion and improve transfusion safety for patients with SCD. This study used data from clinical trials registered at ClinicalTrials.gov as #NCT02098863 and NCT00760656.

Indexed as

Exome SequencingGenotypeMachine LearningRh-Hr Blood-Group SystemAllelesAnemia, Sickle CellGenotyping TechniquesHumansRHCE protein, humanRh-Hr Blood-Group SystemRho(D) antigen

Identifiers

PMID38522094
PMCPMC11157206
OpenAlexW4393128835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.